Provider Forum January 13, :00 PM
|
|
|
- Heather Austin
- 10 years ago
- Views:
Transcription
1 Provider Forum January 13, :00 PM Agenda Welcome and Updates Beth Lackey, Provider Network Director NCTRACKS and Taxonomies Gap Analysis/Needs Assessment IPRS Utilization Analysis B3 Funds PBHM Performance Measures Credentialing/Enrollment/CAQH Relative as Direct Support Employee Updates Transitions to Community Living Learning Collaboratives Communications/Media Larry Holcombe, Provider Network Manager Regina Haynes, Care Coordination Supervisor Stacy Bryant, Communications Officer Partners Training Academy Janet Noblett, Training Coordinator NCTOPPS Jackie Copeland, Waiver Contract Manager Provider Council Kevin Oliver/Margaret Mason Western Regional Partnership Miscellaneous/Wrap Up Paul Caldwell, Chief Community Relations Officer
2 North Carolina Department of Health and Human Services Pat McCrory Governor Aldona Z. Wos, M.D. Ambassador (Ret.) Secretary, DHHS Division of Mental Health, Developmental Division of Medical Assistance Disabilities and Substance Abuse Services 2501 Mail Services Center 3001 Mail Services Center Raleigh, North Carolina Raleigh, North Carolina Tel Fax Tel Fax Robin Gary Cummings, M.D. Courtney M. Cantrell, Ph.D. Deputy Secretary for Health Services Director Director, Division of Medical Assistance MCO Communication Bulletin #J114 Date: January 9, 2015 To: From: Subject: LME-MCOs Mabel McGlothlen, LME System Performance Team Leader, DMH/DD/SAS, and Kathy Nichols, Lead Waiver Program Manager, Contracts Section, DMA Provider Enrollment The purpose of this bulletin is to inform that providers are now able to update their provider record in NCTracks ( via the managed change request process that can be accessed through the provider portal. Please encourage all providers in your network to keep their records up to date. This will assist in ensuring accurate data and will allow for more seamless encounter data transmission. LME-MCOs will be able to receive updates to the provider file via the weekly Global Provider File (GPF) interface transmission from NCTracks. Cc: Robin Gary Cummings, M.D., DMA Dave Richard, DHHS DMA Leadership Team DMH/DD/SAS Leadership Team Mary Hooper, NCCCP An Equal Opportunity / Affirmative Action Employer
3 North Carolina Department of Health and Human Services Pat McCrory Governor Aldona Z. Wos, M.D. Ambassador (Ret.) Division of Mental Health, Developmental Division of Medical Assistance Disabilities and Substance Abuse Services 2501 Mail Services Center 3001 Mail Services Center Raleigh, North Carolina Raleigh, North Carolina Tel Fax Tel Fax Robin Gary Cummings, M.D. Courtney M. Cantrell, Ph.D. Deputy Secretary for Health Services Director Director, Division of Medical Assistance MCO Communication Bulletin #J115 Date: January 9, 2015 To: From: Subject: LME-MCOs Mabel McGlothlen, LME System Performance Team Leader, DMH/DD/SAS, and Kathy Nichols, Lead Waiver Program Manager, Contracts Section, DMA Taxonomy The purpose of this bulletin is to outline the process for how to use the updated taxonomy list. During our recent Core Team calls, we discussed issues with taxonomies and their impact on denied claims (this applies to Medicaid Encounter claims, not claims where DMH/DD/SAS would be the payer). To address this issue, your agency was asked to submit a list of the current taxonomies. Staff at DMA then reviewed those taxonomies and provided a list of taxonomies cross-walked with those in the NCTracks system that should not deny claims. The compiled list is not expected to be a comprehensive list of taxonomies that would not be accepted but a stepping stone toward getting a greater proportion of encounter claims to process to acceptance. This clarification comes as a result of the Core Team discussions and is intended to help inform LME-MCO staff how they should use the taxonomy crosswalk list. Once LME-MCOs modify their systems to stop submitting codes not accepted by NCTracks, DMA will reprocess these claims that were previously denied. When the claims are reprocessed, NCTracks will replace the disallowed taxonomy with the cross-walked taxonomy. Where the old taxonomy cross-walks to exclude, the claim would be denied. In order to streamline this process, LME-MCOs shall: 1) Change your claims processing systems to disallow all the taxonomies for Medicaid reimbursement that were on the list and provide DMA a date when the change will be implemented into your system. This is an important step that will help ensure that the system is in line with that of NCTracks when it comes to provider taxonomies. Presumably, the provider would receive an Explanation of Benefits (EOB) outlining the reason for the denial An Equal Opportunity / Affirmative Action Employer
4 Page 2 of 2 Re: Taxonomy January 9, ) Work with any providers using the disallowed taxonomies to identify an NCTracks accepted taxonomy that providers can bill. The LME-MCO should instruct their providers to log on to the NCTracks Provider Portal to verify their information including their taxonomy code(s). If any of their information in NCTracks needs to be updated, they need to fill out a Managed Change Request (MCR) while in the NCTracks Provider Portal, then notify the LME-MCO of the changes. The LME-MCOs should reinforce to their contract providers that the providers are now responsible for maintaining and updating their information in NCTracks, as well as reporting changes to the LMC-MCO. 3) Educate and work with providers to ensure that what is submitted is both legitimate and accepted by NCTracks. LME-MCOs are not being asked to alter any claims information that is sent to them, but might need to assist the provider to ensure that they have entered legitimate claims that NCTracks will accept. For example, 103TA0400X is not accepted but 103T00000X is sufficient. Both are taxonomies for Psychologists, but the one that NCTracks does not accept is more specific. As another example, 101YP1600X is Pastoral Counselor and there could possibly be no other taxonomies that would fit that provider. If that is the case, then DMA will not pay for service for such a provider. For one last example, 208M00000X is a Hospitalist. In the crosswalk, DMA listed X, which is Pediatrics. This does not mean that all Hospitalists should be enrolled under the Pediatrics taxonomy. Rather, the provider should see if there is an appropriate taxonomy that is in the list that NCTracks approves. If you have questions regarding this request, please send them via electronic mail to: [email protected] or [email protected] Cc: Robin Gary Cummings, M.D., DMA Dave Richard, DHHS DMA Leadership Team DMH/DD/SAS Leadership Team Mary Hooper, NCCCP An Equal Opportunity / Affirmative Action Employer
5 North Carolina Department of Health and Human Services Pat McCrory Governor Aldona Z. Wos, M.D. Ambassador (Ret.) Secretary, DHHS Division of Mental Health, Developmental Division of Medical Assistance Disabilities and Substance Abuse Services 2501 Mail Services Center 3001 Mail Services Center Raleigh, North Carolina Raleigh, North Carolina Tel Fax Tel Fax Robin Gary Cummings, M.D. Courtney M. Cantrell, Ph.D. Deputy Secretary for Health Services Director Director, Division of Medical Assistance MCO Communication Bulletin #J116 Date: January 9, 2015 To: From: Subject: LME-MCOs Mabel McGlothlen, LME System Performance Team Leader, DMH/DD/SAS, and Kathy Nichols, Lead Waiver Program Manager, Contracts Section, DMA Associate Level Licensed Providers: Direct Enrollment The purpose of this bulletin is to notify associate level licensed providers that they must directly enroll by June 30, 2015 to provide Medicaid and state funded outpatient behavioral health services. Associate level licensed providers must apply and enroll through the LME-MCO with which they wish to contract. Effective July 1, 2015, if the associate level licensed provider wishes to provide services to Medicaid beneficiaries age 0 to 3, Health Choice beneficiaries, or legal aliens, the associate level professional must enroll with DMA by contacting Computer Sciences Corporation (CSC). The associate level licensed provider will need to be enrolled with both DMA (through CSC) and the LME- MCO if they wish to provide services to multiple populations. The Division of Public Health provides services to individuals who are age 0-3 and are not Medicaid or Health Choice eligible. DMH/DD/SAS provides services to individuals who have had their third birthday and older. Associate level licensed providers enrolling with DMA (through CSC) or the LME-MCO will enroll under the taxonomy code of their respective profession. For example, the Associate Level Licensed Clinical Social Worker will enroll under the taxonomy code for a Licensed Clinical Social Worker An Equal Opportunity / Affirmative Action Employer
6 Re: Associate Level Licensed Providers: Direct Enrollment January 9, 2015 For claims submitted through NC Tracks, the rate for the associate level licensed provider is the same as the rate for their fully licensed counterpart. However, LME-MCOs have the ability to set their own rates for services. Therefore, associate level licensed providers should contact the LME-MCO for information regarding rates. Associate level licensed providers will need to obtain their own National Provider Identifier (NPI) number if they do not have one. To apply for an NPI number, please see the instructions on the following website Associate level licensed providers may contact CSC ( ) with questions regarding enrollment with DMA. Associate level licensed providers should contact their LME-MCO regarding enrollment. As outlined in section 6.2 of the outpatient Clinical Coverage Policy 8C, associate level licensed providers are allowed to bill incident-to their supervising physician or bill through the LME-MCO until the associate level licensed provider is able to directly enroll with the LME-MCO. The policy states that when the associate level licensed provider is able to direct enroll, then DMA will discontinue the associate level license provider incident to policy. The incident to policy change will not impact providers receiving state-funded reimbursement as DMH/DD/SAS does not support incident to billing. Associate level licensed providers will be able to continue billing incident to their supervising physician for Medicaid or bill HCPCS codes through a willing LME-MCO for Medicaid and/or state-funded behavioral health outpatient services until they have completed direct enrollment, or until June 30, 2015, whichever comes first. Effective July 1, 2015: 1. DMA will change the outpatient Clinical Coverage Policy 8C and remove the section on "incident to" billing for associate level licensed providers as well as remove the section allowing associate licensed level providers to bill HCPCS codes (H0001, H modifiers, H0005 and H0031) through the LME- MCO. 2. DMH/DD/SAS will also eliminate HCPCS code billing through the LME-MCO for state-funded outpatient services at the same time. All associate level licensed providers are required to have supervision from a supervisor approved by their licensing board. This supervision is critical to ensuring quality of services for beneficiaries being served by associate level licensed providers. Each associate level licensed provider is required to ensure that they meet the supervision requirements set forth by their respective licensing board. The links to the rules pertaining to the respective board s supervision requirements found in the North Carolina Administrative Code are as follows: Marriage and Family Licensure Board: Substance Abuse Professional Practice Board: %20occupational%20licensing%20boards%20and%20commissions/chapter%2068%20- %20substance%20abuse%20professional%20practice%20board/21%20ncac%2068% pdf An Equal Opportunity / Affirmative Action Employer 2
7 Re: Associate Level Licensed Providers: Direct Enrollment January 9, 2015 North Carolina Board of Licensed Professional Counselors: North Carolina Social Work Certification and Licensure Board: If you have questions, please contact Kathy Nichols at: for Medicaid and Health Choice related questions, and Mabel McGlothlen at: for state-funded questions. Cc: Robin Gary Cummings, M.D., DMA Dave Richard, DHHS DMA Leadership Team DMH/DD/SAS Leadership Team Mary Hooper, NCCCP An Equal Opportunity / Affirmative Action Employer 3
8 North Carolina Department of Health and Human Services Pat McCrory Governor Aldona Z. Wos, M.D. Ambassador (Ret.) Secretary, DHHS Division of Mental Health, Developmental Division of Medical Assistance Disabilities and Substance Abuse Services 2501 Mail Services Center 3001 Mail Services Center Raleigh, North Carolina Raleigh, North Carolina Tel Fax Tel Fax Robin Gary Cummings, M.D. Courtney M. Cantrell, Ph.D. Deputy Secretary for Health Services Director Director, Division of Medical Assistance MCO Communication Bulletin #J117 Date: January 9, 2015 To: From: Subject: LME-MCOs Mabel McGlothlen, LME System Performance Team Leader, DMH/DD/SAS, and Kathy Nichols, Lead Waiver Program Manager, Contracts Section, DMA Clarification of Joint Communication Bulletin #J098: MCM The purpose of this bulletin is to describe some options to address the assessment and discharge planning functions necessary in a hospital ED environment without utilizing mobile crisis management: 1. Contract with independent practitioner (LCSW, LPC, Psychologist) to offer outpatient evaluations and discharge on an on-call basis in the ED. 2. Embed an administrative-level individual (or place them on-call to work with ED without necessarily having to be IN the ED) to coordinate discharge and follow-up to ensure aftercare is received. For example, non-clinical care coordination staff could make phone calls to help arrange aftercare transportation and communicate with existing providers for the individual being discharged from the ED. 3. Use identified STR staff specifically for this purpose; it might work well for an ED that has telepsychiatry. Please note that section 6.13 of the LME MCO contract states: PIHP shall coordinate and monitor Behavioral Health hospital and institutional admissions and discharges, including discharge planning. An alternative service definition may also be an option that can be discussed with DMA An Equal Opportunity / Affirmative Action Employer
9 Page 2 of 2 Re: Clarification of Joint Communication Bulletin #J098: MCM January 9, 2015 Please direct any questions to [email protected] or [email protected]. Cc: Robin Gary Cummings, M.D., DMA Dave Richard, DHHS DMA Leadership Team DMH/DD/SAS Leadership Team Mary Hooper, NCCCP An Equal Opportunity / Affirmative Action Employer
10 N.C. Medicaid and N.C. Health Choice Preferred Drug List Changes Effective with an estimated date of service of January 1, 2015, the N.C. Division of Medical Assistance (DMA) will make changes to the N.C. Medicaid and N.C. Health Choice (NCHC) Preferred Drug List (PDL). It is the expectation of Partners Behavioral Health Management that providers are aware of the importance of prescribers prescribing medications that are covered by a patient s insurance, in an effort to reduce risk of the patient not filling/taking medication because they cannot afford it and to increase medication adherence. The following list is available in the December 2014 Medicaid Bulletin available using the following link: n.htm#pdl Below are highlights of some of the changes that will occur. The prior authorization criteria will be removed from the leukotriene class New classes are being added: o Under TOPICAL, Imidazoquinolinamines o Under MISCELLANEOUS, Epinephrine, Self-Injected; Estrogen Agents, Vaginal Preparations; Glucocorticoid Steroids, Oral Some mental health pharmaceuticals will have non-preferred options for the first time. Below is what the PDL will look like January 1, 2015 Preferred ANTIDEPRESSANTS- Other Non-Preferred bupropion (generic for Wellbutrin ) Aplenzin bupropion SR (generic for Wellbutrin SR ) Brintellix bupropion XL (generic for Wellbutrin XL ) desvenlafaxine ER (generic for Pristiq ) Cymbalta duloxetine (generic for Cymbalta ) maprotiline (generic for Ludiomil ) Effexor XR Capsules mirtazapine (generic for Remeron ) Emsam Nardil Fetzima Corporate Office 901 South New Hope Rd. Gastonia, NC Elkin Region Office 200 Elkin Business Park Dr. Elkin, NC Hickory Region Office 1985 Tate Blvd. SE, Suite 529 Hickory, NC Administration: Customer Services: HOPE (4673) Website:
11 Preferred ANTIDEPRESSANTS- Other Non-Preferred Parnate Forfivo XL phenelzine (generic for Nardil ) Khedezla Savella nefazodone (generic for Serzone ) tranylcypromine (generic for Parnate ) Oleptro ER trazodone (generic for Desyrel ) Pristiq venlafaxine (generic for Effexor ) Remeron venlafaxine ER capsules (generic for Effexor XR Capsules ) Remeron ODT venlafaxine ER tablets (generic for Effexor XR Tablets ) Viibryd Wellbutrin Wellbutrin SR Wellbutrin XL
12 ANTIDEPRESSANTS -Selective Serotonin Reuptake Inhibitor (SSRI) Preferred Non-Preferred citalopram (generic for Celexa ) Brisdell escitalopram tablet (generic for Lexapro Tablet) Celexa fluoxetine capsule (generic for Prozac Capsule) escitalopram solution (generic for Lexapro Solution) fluoxetine solution (generic for Prozac Solution) fluoxetine DR 90mg Caps (generic for Prozac Weekly ) fluvoxamine (generic for Luvox ) fluvoxamine ER (generic for Luvox CR ) paroxetine (generic for Paxil ) Lexapro sertraline (generic for Zoloft ) Luvox CR paroxetine CR (generic for Paxil CR ) Paxil Paxil CR Pexeva Prozac Prozac Weekly Sarafem Zoloft
13 Preferred ANTIHYPERKINESIS Non-Preferred Adderall XR amphetamine salt combo XR capsules (generic for Adderall XR) Adderall Concerta amphetamine salt combo tablets (generic for Adderall) dexmethylphenidate (generic for Focalin ) clonidine ER (Kapvay ) dexmethylphenidate XR (generic for Focalin XR) Daytrana dextroamphetamine ER (generic for Dexedrine Spansules ) Desoxyn dextroamphetamine solution (generic for ProCentra ) Dexedrine Spansules Intuniv dextroamphetamine (generic for DextroStat ) methamphetamine (generic for Desoxyn ) Focalin Methylin Chewable Tablet Focalin XR methylphenidate CD capsules (generic for Metadate CD) Kapvay methylphenidate LA capsules (generic for Ritalin LA) Metadate CD methylphenidate solution (generic for Methylin Soluton)
14 Preferred ANTIHYPERKINESIS Non-Preferred Metadate ER ProCentra Methylin Solution Ritalin SR methylphenidate ER tablets (generic for Concerta ) Zenzedi methylphenidate ER tablets (generic for Ritalin SR) methylphenidate tablets (generic for Methylin /Ritalin ) Quillivant XR Ritalin Ritalin LA Strattera Vyvanse
15 ATYPICAL ANTIPSYCHOTICS Injectable Long Acting (Trial and Failure of only 1 preferred required) Preferred Non-Preferred Abilify Maintena fluphenazine decanoate (generic for Prolixin decanoate ) Haldol decanoate haloperidol decanoate (generic for Haldol decanoate ) Invega Sustenna Risperdal Consta Zyprexa Relprevv
16 Preferred ATYPICAL ANTIPSYCHOTICS Oral (Trial and Failure of only 1 preferred required) Non-Preferred Abilify Clozaril clozapine (generic for Clozaril ) Fanapt Titration Pack clozapine ODT (generic for FazaClo ) FazaClo Fanapt Geodon Invega olanzapine/fluoxetine (generic for Symbyax ) Latuda Risperdal olanzapine (generic for Zyprexa ) Risperdal M olanzapine ODT (generic for Zyprexa Zydis) Seroquel quetiapine (generic for Seroquel ) Versacloz risperidone (generic for Risperdal ) Zyprexa risperidone ODT (generic for Risperdal M ) Zyprexa Zydis Saphris Seroquel XR Symbyax ziprasidone (generic for Geodon )
17 If you have a patient who is stable on a non-preferred product, and want them to continue on it, you may fill out a standard drug request prior authorization form found at These forms will be accepted beginning December 1, Forms must be submitted by December 30, 2014 to have approved prior authorizations active in the system by January 1, Update on preferred brands with non-preferred generic equivalents In addition to the changes above, preferred brands with non-preferred generic equivalents will be updated and are listed in the chart below: Brand Name Generic Name Accolate Zafirlukast Adderall XR Amphetamine Salt Combo ER Aldara Imiquimod Alphagan P Brimonidine Astelin/Astepro Azelastine Hydrochloride Bactroban Mupirocin Benzaclin Clindamycin/Benzoyl Peroxide Cardizem LA Matzim LA Catapress-TTS Clonidine Patches Cedax Ceftibuten Cymbalta Duloxetine Derma-Smoothe-FS Fluocinolone 0.01% Oil
18 Brand Name Generic Name Desoxyn Methamphetamine Dexedrine Spansules Dextroamphetamine Diastat/Diastat Accudial Diazepam Rectal Differin Adapalene Diovan Valsartan Diovan HCT Valsartan / Hydrochlorothiazide Duetact Pioglitazone / Glimepiride Epivir HBV Lamivudine HBV Entocort EC Budesonide Epi-Pen Epinephrine Exforge Amlodipine / Valsartan Exelon Rivastigmine Focalin / Focalin XR Dexmethylphenidate Gabitril Tiagabine Gris-Peg Griseofulvin Ultramicrosize Hepsera Adefovir Kadian ER Morphine Sulfate ER Lovenox Enoxaparin
19 Brand Name Generic Name Metadate CD Methylphenidate CD Methylin Solution Methylphenidate Solution Metrogel Vaginal Metronidazole Gel Vaginal Natroba Spinosad Niaspan ER Niacin ER Opana ER Oxymorphone ER Prandin Repaglinide PrevPac Lansoprazole / Amoxicillin / Clarithromycin Provigil Modafinil Pulmicort 0.25mg/2ml, 0.5mg/2ml Budesonide 0.25mg/2ml, 0.5mg/2ml Ritalin LA Methylphenidate ER Symbyax Olanzapine / Fluoxetine Tobradex Suspension Tobramycin/Dexamethasone Susp Toprol XL Metoprolol Succinate Travatan Travoprost Verelan PM Verapamil ER PM Zovirax Ointment Acyclovir Ointment
20
21 NC TOPPS Timely Submission Compliance since Merger In July 2012 (Partners Behavioral Health Management) : 1st QTR 93.5% : 4th QTR 85% : 3rd QTR : 2nd QTR : 1st QTR : 4th QTR : 3rd QTR : 2nd QTR : 1st QTR State Standard 78.8% 78.30% 82.7% 82.2% 86.3% 86.9% 87.1% 90% 70% 75% 80% 85% 90% 95% Enter Presentation Title 1/12/2015 2
22 The State benchmark for timely submission of NC TOPPS is 90%. For the 1st quarter , Partners compliance is 93.5%. Partners BHM currently had 116 Providers registered within the NC TOPPS system during the first quarter. (Multiple sites included) This quarter 55 Providers met the 90% submission standard. 46 of the 55 Providers had 100% submission rate for compliance It should also be noted that 43 Providers had no requirements for updates. NC TOPPS Superstars 1/12/2015 3
23 Agency Name Agency City % Received on time A Caring Alternative Morganton 100.0% Access Family Services, Inc. Gastonia 100.0% Alexander Youth Network Dallas 100.0% Alexander Youth Network Spindale 100.0% Alexander Youth Network Charlotte 100.0% Barium Springs Home for Children Statesville 100.0% Beaty Recovery Services Gastonia 100.0% Standard Met NC TOPPS Superstars 1/12/2015 4
24 Agency Name Agency City % Received on time Burke Council on Alcoholism & Chemical Dependency Morganton 100.0% Carolina Therapeutic Services, Inc. Gastonia 100.0% Children's Advocacy Network Lincolnton 100.0% Children's Advocacy Network Gastonia 100.0% Clay, Wilson, and Associates/Cognitive Connection Hickory 97.8% Cornerstone Treatment Facility Hope Mills 100.0% Daymark Recovery Services Statesville 91.8% Standard Met 1/12/2015 5
25 Provider Agency Agency City % Received on time Daymark Recovery Services Yadkinville 100.0% Daymark Recovery Services Mount Airy 96.6% Eliada Homes, Inc. Asheville 100.0% Families First Support Services, LLC Shelby 92.3% Family NET Newton 100.0% Family NET of Catawba County Hickory 100.0% FOCUS Behavioral Health Services, LLC Hudson 100.0% Standard Met NC TOPPS Superstars 1/12/2015 6
26 Provider Agency Agency City % received on time FOCUS Behavioral Health Services, LLC Morganton 100.0% Gaston Adolescent Center, Inc. Gastonia 100.0% Genesis House, Inc. Gastonia 100.0% Grandfather Home for Children Banner Elk 100.0% Innovative Compliance Solutions Gastonia 100.0% McLeod Center Hickory 96.4% McLeod Center Boone 100.0% McLeod Center Gastonia 100.0% McLeod Center Statesville 100.0% Standard Met NC TOPPS Superstars 1/12/2015 7
27 Provider Agency Provider City % Received on time Monarch Gastonia 100.0% Monarch Shelby 100.0% New Hope Carolinas Rock Hill 100.0% NewPath Youth Services Shelby 100.0% One Love Periodic Services Morganton 100.0% Outreach Management Services Gastonia 97.0% Phoenix Counseling Center Gastonia 99.4% Standard Met NC TOPPS Superstars 1/12/2015 8
28 Provider Agency Provider City % Received on time Standard Met Phoenix Counseling Center Lincolnton 100.0% Phoenix Counseling Center Shelby 100.0% RHA Behavioral Health Services, Inc. Forest City 100.0% Self Concepts Clinical Counseling Services, Inc. Gastonia 100.0% Step's Developmental Academy Charlotte 100.0% Strategic Interventions, Inc. Morganton 100.0% Strategic Interventions, Inc. Yadkinville 100.0% Enter Presentation Title 1/12/2015 9
29 Provider Agency Provider City % Received on time Strategic Interventions, Inc. Marion 100.0% Strategic Interventions, Inc. Yadkinville 100.0% Strategic Interventions, Inc. Greensboro 100.0% Support, Inc. Gastonia 96.8% Support, Inc. Shelby 100.0% The Children's Home, Inc. Winston-Salem 100.0% The Right Choice MWM, Inc. Charlotte 100.0% Standard Met Enter Presentation Title 1/12/
30 Provider Agency Provider City % Received on time Standard Met Thompson Child and Family Focus Matthews 100.0% Top Priority Care Services, LLC Winston-Salem 100.0% Turning Point Homes Charlotte 92.9% Youth Focus, Inc. Greensboro 100.0% Enter Presentation Title 1/12/
31 NC-TOPPS Help Desk: Center for Urban Affairs & Community Services, NC State University: (919) Help Desk: Partners BHM: Sheila Wall, Quality Management Data Analyst, (Gastonia site): (704) (please use only consumer MR# s in s-no identifying information!) Enter Presentation Title 1/12/
32 Enter Presentation Title 1/12/
PSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS. Juanaelena Garcia, MD Psychiatry Director Institute for Family Health
PSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS Juanaelena Garcia, MD Psychiatry Director Institute for Family Health Learning Objectives Learn basics about the various types of medications that
PSYCHOSOMATIC INSTITUTE OF SAN ANTONIO New Patient Information
PSYCHOSOMATIC INSTITUTE OF SAN ANTONIO New Patient Information Name: Last: First: MI: Birth Date: Sex: M F Marital Status: Single Married Divorced Separated Widowed Partnered Other Preferred name: Emergency
Lamictal, lamotrigine Lithium, lithobid, eskalith Depakote, valproate Trileptal, oxcarbazepine Tegretol, equetro, carbamazepine Atypicals (aripiprazole, abilify, olanzapine, zyprexa, invega, risperdal,
Avoid paying too much for your prescriptions
Quality health plans & benefits Healthier living Financial well-being Intelligent solutions 2016 Aetna Rx Step Program Medicine List Avoid paying too much for your prescriptions It s important to try to
Avoid paying too much for your prescriptions 2015 Aetna Rx Step Program Medicine List
Quality health plans & benefits Healthier living Financial well-being Intelligent solutions Avoid paying too much for your prescriptions 2015 Aetna Rx Step Program Medicine List 05.03.392.1 C (10/14) It
Medicines for Treating Depression. A Review of the Research for Adults
Medicines for Treating Depression A Review of the Research for Adults Is This Information Right for Me? Yes, if: A doctor or other health care professional has told you that you have depression. Your doctor
Overview of Mental Health Medication Trends
America s State of Mind Report is a Medco Health Solutions, Inc. analysis examining trends in the utilization of mental health related medications among the insured population. The research reviewed prescription
Medications Used in the Management of Disruptive Behavior Disorders
The following medication chart is provided as a brief guide to some of the medications used in the management of various behavior disorders, along with their potential benefits and possible side effects.
State of Louisiana. Department of Health and Hospitals Bureau of Health Services Financing
Bobby Jindal GOVERNOR State of Louisiana Department of Health and Hospitals Bureau of Health Services Financing Kathy H. Kliebert SECRETARY The purpose of this memo is to advise you that effective September
Arizona Department of Health Services/ Division of Behavioral Health Services Behavioral Health Drug List Effective 1/1/2014
Arizona Department of Health Services/ Division of Behavioral Health Services Behavioral Health Drug List Effective 1/1/2014 The Arizona Department of Health Services, Division of Behavioral Health Services,
Psychiatric Medications: Pearls and Pitfalls. The majority of medications used in patients with psychiatric diagnoses have more than one use.
Psychiatric Medications: Pearls and Pitfalls Rule #1 The majority of medications used in patients with psychiatric diagnoses have more than one use. Without access to the patient s medical record, to review
Psychotropic Medication Reference Chart
Psychotropic Medication Reference Chart Appendix 4.14 This chart is not an all-inclusive list of medications. If you have a question regarding the classification of a medication you may consult websites
Early Morning Waking Excessively Orderly or Perfectionistic
COLLEGE OF MEDICINE Jacksonville 580 W 8 th St T-2 6 th Fl Ste 6005 6266 Dupont Station Ct Department of Psychiatry Jacksonville, FL 32209 Jacksonville, Fl 32217 Division of Adult Psychiatry Phone 904-383-1038
Medications A detailed booklet that describes mental disorders and the medications for treating them includes a comprehensive list of medications.
A detailed booklet that describes mental disorders and the medications for treating them includes a comprehensive list of medications. 2014 Contents Introduction: Mental Health Medications...1 What are
12629 LIBRIUM CHLORDIAZEPOXIDE HCL 12637 LIBRIUM CHLORDIAZEPOXIDE HCL 12645 LIBRIUM CHLORDIAZEPOXIDE HCL 13110 VALIUM DIAZEPAM 13277 VALIUM DIAZEPAM 24406 LITHANE LITHIUM CARBONATE 25836 SURMONTIL TRIMIPRAMINE
Objectives. The use of Psychotropics in Children
Objectives The use of Psychotropics in Children Ashley E. Little, Pharm.D. Psychopharmacology Resident Nova Southeastern University College of Pharmacy Dade County Pharmacy Association To understand current
Psychiatric Evaluation Intake Form
Psychiatric Evaluation Intake Form 1. Patient Contact Information Patient Name Preferred Name Last First MI Address_ Best contact phone number: Email address: Primary Care Physician Tel Fax Pharmacy Phone
Mental Health Medications
Mental Health Medications National Institute of Mental Health U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Contents Mental Health Medications..............................................................1
SECTION M BEHAVIORAL HEALTH SERVICES
Phoenix Health Plan s (PHP) goal for its members is to ensure that behavioral health services are readily available for Title XIX (Medicaid) and the Title XXI (KidsCare) members. Comprehensive behavioral
PSYCHIATRY. Patient Name: Date: / / Date of Birth: / / Age: Pharmacy Name: Pharmacy Phone #:
Patient Name: Date: / / Date of Birth: / / Age: Pharmacy Name: Pharmacy Phone #: Primary Care Physician: Current Therapist/Counselor: How did you hear about us? Internet Insurance Other Providers (specialty):
What are the best treatments?
What are the best treatments? Description of Condition Depression is a common medical condition with a lifetime prevalence in the United States of 15% among adults. Symptoms include feelings of sadness,
ANTIDEPRESSANT MEDICINES. A GUIDE for ADULTS With DEPRESSION
ANTIDEPRESSANT MEDICINES A GUIDE for ADULTS With DEPRESSION August 2007 FAST FACTS ON ANTIDEPRESSANTS The antidepressants in this guide work for treating depression. Most people can find one that makes
CountyCare Appropriate Uses and Safety Edits
CountyCare Appropriate Uses and Safety Edits The health and safety of our members are top priorities for CountyCare. One of the ways we address patient safety is through point-of-sale (POS) edits at the
Stimulants and Nonstimulants for ADHD
Stimulants and Nonstimulants for ADHD Stimulants Adderall and Adderall XR (amphetamine mixtures) Concerta (methylphenidate, extended release) Daytrana (methylphenidate topical patch) Dexedrine and Dexedrine
New Treatments. For Bipolar Disorder. Po W. Wang, MD Clinical Associate Professor Bipolar Disorders Clinic Stanford University School of Medicine
New Treatments For Bipolar Disorder Po W. Wang, MD Clinical Associate Professor Bipolar Disorders Clinic Stanford University School of Medicine Abbott Laboratories AstraZeneca Bristol-Myers Squibb Corcept
Antipsychotics and the Nursing Home
Antipsychotics and the Nursing Home Lisa M. O Hara, PharmD, CGP Corporate Director of Clinical Services The State Operations Manual Part 1: F329 Unnecessary Drugs Medication Management Defined Helps promote
Handout 2 List of medications used to treat mental illness
Navigating Boundaries: Setting Sail With A Mentally Ill Client Handout 2 List of medications used to treat mental illness Information synthesized from www.drugs.com. Additional Information: CR following
PARTNERSHIP HEALTHPLAN OF CALIFORNIA MEDI-CAL PROVIDER MANUAL CLAIMS DEPARTMENT
PARTNERSHIP HEALTHPLAN OF CALIFORNIA MEDI-CAL PROVIDER MANUAL CLAIMS DEPARTMENT X.J. Mental Health Services 1. For claims with dates of service on or before January 1, 2014: Mental Health Services are
The Antidepressants: Treating Depression. Comparing Effectiveness, Safety, and Price
The Antidepressants: Treating Depression Comparing Effectiveness, Safety, and Price Our Recommendations Antidepressants can improve the symptoms of depression, but they can also have serious side effects.
Depression. Using Antidepressants to Treat. Contents. 2: Our Recommendations. 3: Welcome. 5: What Are Antidepresssants and Who Needs Them?
Using Antidepressants to Treat Depression Comparing Effectiveness, Safety, and Price Contents 2: Our Recommendations 3: Welcome 5: What Are Antidepresssants and Who Needs Them? 9: Choosing an Antidepresssant
Oral Fluid Drug Testing March 23 rd, 2015
Oral Fluid Drug Testing March 23 rd, 2015 Drug Testing Options Breath Blood Meconium Vitreous Hair Sweat Urine Oral Drug Testing Options Oral Fluid and Blood and Breath Actual levels (immediate use, up
EMORY CLINIC, INC. Brain Health Center 12 Executive Park Dr. Atlanta, GA 30329 404-728-6302
New Patient Packet 03/10/2015 EMORY CLINIC, INC. Brain Health Center 12 Executive Park Dr. Atlanta, GA 30329 404-728-6302 Thank you for allowing us to assist in your care. We look forward to meeting you.
Objectives. Depression and Anxiety: Latest in treatment recommendations. At the conclusion of this presentation the attendee will be able to:
Depression and Anxiety: Latest in treatment recommendations Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC President, Fitzgerald Health Education Associates, Inc., North Andover, MA Family
Professional Treatment Services in Facility-Based Crisis Program Children and Adolescents
Professional Treatment Services in Facility-Based Crisis Program Children and Adolescents Medicaid and North Carolina Health Choice (NCHC) Billable Service WORKING DRAFT Revision Date: September 11, 2014
Using Antipsychotics to Treat: Depression. Comparing Effectiveness, Safety, and Price
Using Antipsychotics to Treat: Depression Comparing Effectiveness, Safety, and Price Our Recommendations Although antipsychotics were developed to treat schizophrenia, newer ones are sometimes used to
Depression. Medicines To Help You
Medicines To Help You Depression Use this guide to help you talk to your doctor, pharmacist, or nurse about your medicines for depression. The guide lists all of the FDA-approved products now available
What Is NC-TOPPS? mental health substance abuse consumers
What Is NC-TOPPS? NC-TOPPS is a web-based system for gathering outcome and performance data on behalf of mental health and substance abuse consumers who are receiving a qualifying service in North Carolina
A Guide to Tourette Syndrome Medications by John T. Walkup M.D.
llllllllllllllll A TSA MEDICAL PUBLICATION A Guide to Tourette Syndrome Medications by John T. Walkup M.D. This publication is intended to provide information about Tourette Syndrome, its management and
Medication Side Effects:
Medication Side Effects: Staying Healthy While on Psychotropic Medications Megan Maroney PharmD, BCPP Clinical Assistant Professor Ernest Mario School of Pharmacy Rutgers the State University of New Jersey
Treatment Options for ADHD in Children and Teens. A Review of Research for Parents and Caregivers
Treatment Options for ADHD in Children and Teens A Review of Research for Parents and Caregivers Is This Summary Right for Me? Yes, if: A doctor said that your child or teen has attention deficit hyperactivity
Attachment E Annual ESTIMATED Usage based on 2007 volumes
Description Quantity # Orders Dept ABILIFY 10MG TABLET 660 22 Children's Vil. ABILIFY 15MG TABLET 150 4 Children's Vil. ABILIFY 20MG TABLET 300 10 Children's Vil. ABILIFY 5MG TABLET 840 20 Children's Vil.
Melissa D. Carter, JD Barton Child Law & Policy Center Brent Wilson, MD Child Welfare Collaborative
Melissa D. Carter, JD Barton Child Law & Policy Center Brent Wilson, MD Child Welfare Collaborative Scope of the Problem Legal and Policy Considerations Social Work and Medical Practices Advocacy Opportunities
Serenity Psychiatry, LLC Mimi Armellino, DO Of Coastal Counseling Associates. Patient History Form
Serenity Psychiatry, LLC Mimi Armellino, DO Of Coastal Counseling Associates Patient History Form Name Date Age DOB SSN Address City State ZIP Patient s Telephone (H) (W) (Cell) Email Job Title or School
Psychotropic Medication
Page 1 T I P S F O R P R A C T I C E Psychotropic Medication Psychotropic medications are symptomatic medications that affect attention, emotions, or behaviors. Communication between the physician, NDHHS
Updated MAR 26, 2013 Myelography Seizures:
Updated MAR 26, 2013 Myelography Medications to be evaluated prior to myelography. This list is to assist the radiologist, pharmacist, and radiology technologist in evaluating medication risk associated
Attention Deficit Hyperactivity Disorder
Attention Deficit Hyperactivity Disorder Spring 2015 Continuing Education John Erramouspe, PharmD, MS Idaho State University College of Pharmacy 208-282-3019 [email protected] I have no relevant
Member Rights & Responsibilities
Member Rights & Responsibilities Member Rights and Responsibilities Blue KC has updated our Member Rights & Responsibilities to be consistent across all of our HMO and PPO products. Blue KC members have:
POPULAR DEPRESSION MEDICATIONS
Popular Depression Medications A Helpful Guide to Antidepressant Drugs POPULAR DEPRESSION MEDICATIONS A Helpful Guide to Antidepressant Drugs Popular Depression Medications A Helpful Guide to Antidepressant
2014 Valley Baptist Medicare D Formulary Step Therapy Criteria
2014 Valley Baptist Medicare D Formulary Step Therapy Products Affected ACTONEL TAB Last Updated 11/1/2014 Requires a trial of alendronate. 1 APLENZIN TAB Patient must have tried bupropion SR or bupropion
Evaluating Prescription Drugs Used to Treat: Attention Deficit Hyperactivity Disorder (ADHD) Comparing Effectiveness, Safety, and Price
Evaluating Prescription Drugs Used to Treat: Attention Deficit Hyperactivity Disorder (ADHD) Comparing Effectiveness, Safety, and Price Contents Our Recommendations...........................................
Recognition and Treatment of Depression in Parkinson s Disease
Recognition and Treatment of Depression in Parkinson s Disease Web Ross VA Pacific Islands Health Care System What is depression? Depression is a serious medical condition that affects a person s feelings,
May 31, 2013. Ms. Debra Lansey American College of Physicians 190 North Independence Mall West Philadelphia, PA 19106
P.O. Box 30449 Salt Lake City, UT 84130-0449 May 31, 2013 Ms. Debra Lansey American College of Physicians 190 North Independence Mall West Philadelphia, PA 19106 Re: Pharmacy Benefit Coverage Changes Effective
Drug Class Review Drugs for Fibromyalgia
Drug Class Review Drugs for Fibromyalgia Final Original Report April 2011 The Agency for Healthcare Research and Quality has not yet seen or approved this report. The purpose of the is to summarize key
Treatment Facilities Amended Date: October 1, 2015. Table of Contents
Table of Contents 1.0 Description of the Procedure, Product, or Service... 1 1.1 Definitions... 1 2.0 Eligibility Requirements... 1 2.1 Provisions... 1 2.1.1 General... 1 2.1.2 Specific... 1 2.2 Special
Product Catalog. 65862-0073-60 Abacavir Tablets 300 mg 60 80 80 AB Ziagen Yellow
65862-0073-60 Abacavir Tablets 300 mg 60 80 80 AB Ziagen Yellow 13107-0058-01 Acetaminophen & Codeine Tablets, C-III 300 mg / 15 mg 100 216 216 AA Tylenol-Codeine White/Off-White 13107-0059-01 Acetaminophen
MEDICATIONS AND TOURETTE S DISORDER: COMBINED PHARMACOTHERAPY AND DRUG INTERACTIONS. Barbara Coffey, M.D., Cheston Berlin, M.D., Alan Naarden, M.D.
MEDICATIONS AND TOURETTE S DISORDER: COMBINED PHARMACOTHERAPY AND DRUG INTERACTIONS Barbara Coffey, M.D., Cheston Berlin, M.D., Alan Naarden, M.D. Introduction Tourette Syndrome (TS) or Tourette s Disorder
ADHD Agents (Adult) Prior Authorization Criteria
ADHD Agents (Adult) Prior Authorization Criteria Brand Generic Dosage Form Adderall amphetamine/dextroamphetamine oral tablet a Adderall XR amphetamine/dextroamphetamine extended-release oral capsule Concerta
Psychiatric Rehabilitation Clinical Coverage Policy No: 8D-1 Treatment Facilities Revised Date: August 1, 2012. Table of Contents
Table of Contents 1.0 Description of the Procedure, Product, or Service... 1 2.0 Eligible Recipients... 1 2.1 Provisions... 1 2.2 EPSDT Special Provision: Exception to Policy Limitations for Recipients
Depression Flow Chart
Depression Flow Chart SCREEN FOR DEPRESSION ANNUALLY Assess for depression annually with the PHQ-9. Maintain a high index of suspicion in high risk older adults. Consider suicide risk and contributing
North Carolina Department of Health and Human Services
North Carolina Department of Health and Human Services Beverly Eaves Perdue, Governor Lanier M. Cansler, Secretary Division of Mental Health, Developmental Division of Medical Assistance Disabilities and
YOUR MEDICATIONS WHAT YOU SHOULD KNOW
YOUR MEDICATIONS WHAT YOU SHOULD KNOW A Handbook For People With Developmental Disabilities Developmental Disabilities Area Board 10 Developmental Disabilities Area Board 10 411 N. Central Avenue Suite
Running the Numbers. A Periodic Feature to Inform North Carolina Health Care Professionals About Current Topics in Health Statistics
Running the Numbers A Periodic Feature to Inform North Carolina Health Care Professionals About Current Topics in Health Statistics A Snapshot of North Carolina s Public Mental Health, Developmental Disabilities,
A few general principles regarding medications are important to consider before initiating therapy in individuals diagnosed with a dementia
MEDICATIONS USED FOR THE MANAGEMENT OF DEMENTIA AND RELATED BEHAVIORIAL COMPLICATIONS* R.Ron Finley, B.S Pharm, R.Ph,CGP, Aimee Loucks, Pharm. D., Gil D. Rabinovici, M.D The following is intended to be
Medications for Huntington s Disease Vicki Wheelock, M.D.
Medications for Huntington s Disease Vicki Wheelock, M.D. Director, HDSA Center of Excellence at UC Davis June 4, 2013 Outline Introduction and disclaimers Medications for cognitive symptoms Medications
MEDICATIONS USED FOR BEHAVIORAL & EMOTIONAL DISORDERS
MEDICATIONS USED FOR BEHAVIORAL & EMOTIONAL DISORDERS A GUIDE FOR PARENTS, FOSTER PARENTS, FAMILIES, YOUTH, CAREGIVERS, GUARDIANS, AND SOCIAL WORKERS Final May 10, 2010 Overview This booklet is a guide
remeron user reviews remeron medicine remeron suicide
Overdose symptoms may occur using therapeutic dosages, antidepressants remeron the risk of side effects to FDA at 1-800-FDA-1088. The most common lorazepam side effects. This material is provided for educational
University of Florida & Shands Adult Psychiatry Outpatient Clinic Intake Form
University of Florida & Shands Adult Psychiatry Outpatient Clinic Intake Form Date Name Age Address Home phone Work phone Cell phone What issue(s) bring(s) you to the Psychiatry Clinic? What has been stressing
North Carolina Department of Health and Human Services
North Carolina Department of Health and Human Services Pat McCrory Governor Aldona Z. Wos, M.D. Ambassador (Ret.) Secretary DHHS To Whom It May Concern: The North Carolina Department of Health and Human
CABHAs and non-cabha agencies may provide Comprehensive Clinical Assessments, Medication Management, and Outpatient Therapy.
Page 7c.1b 4.b Early and periodic screening, diagnostic and treatment services for individuals under 21 years of age, and treatment of conditions found. (continued) Critical Access Behavioral Health Agency
Understanding Psychosis
Understanding Psychosis Resources and Recovery Y YOUTH Phone: 1-651-645-2948 Toll Free: 1-888-NAMI-HELPS www.namihelps.org NAMI Minnesota champions justice, dignity, and respect for all people affected
How To Manage Medication For Children And Adolescents With Attentiondeficit/Hyperactivity Disorder
National Resource Center on AD HD A program of CHADD 3 WHAT WE KNOW Managing Medication for Children and Adolescents with ADHD * Individuals with attention-deficit/hyperactivity disorder (ADHD) experience
PROVIDER CREDENTIALING & RE-CREDENTIALING CRITERIA MEDICAID. Credentialing & Re-Credentialing Criteria Medicaid qmc092314 Page 1 of 15
PROVIDER CREDENTIALING & RE-CREDENTIALING CRITERIA MEDICAID Credentialing & Re-Credentialing Criteria Medicaid qmc092314 Page 1 of 15 Sandhills Center Credentialing Criteria Agency/Facility: The agency/facility
BIPOLAR DISORDER A GUIDE FOR INDIVIDUALS AND FAMILIES FOR THE TREATMENT OF BIPOLAR DISORDER IN ADULTS
BIPOLAR DISORDER A GUIDE FOR INDIVIDUALS AND FAMILIES FOR THE TREATMENT OF BIPOLAR DISORDER IN ADULTS A publication of the Massachusetts Department of Mental Health and the Massachusetts Division of Medical
The following is a sample of psychotropic drug warnings that drug regulatory agencies
Chronology of International Drug Regulatory Agency Warnings about Psychotropic Drugs The following is a sample of psychotropic drug warnings that drug regulatory agencies around the world have issued.
Depression in Older Adults A Guide for Patients and Families
The Expert Consensus Guideline Series Depression in Older Adults A Guide for Patients and Families Reprinted from: Alexopoulos GS, Katz IR, Reynolds CF III, Carpenter D, and Docherty JP. The Expert Consensus
MOOD DISORDERS PART II BIPOLAR AFFECTIVE DISORDER (BAD) Todd Stull, M.D. James Sorrell, M.D.
MOOD DISORDERS PART II BIPOLAR AFFECTIVE DISORDER (BAD) Todd Stull, M.D. James Sorrell, M.D. BIPOLAR AFFECTIVE DISORDER (BAD) General Assessment is challenging Input important Change in level of functioning
ATYPICALS ANTIPSYCHOTIC MEDICATIONS
The atypical antipsychotics are a class of drugs that are used to treat a number of behavioral health disorders, including schizophrenia, other psychotic disorders, mood disorders, and behavioral agitation
TN No: 09-024 Supersedes Approval Date:01-27-10 Effective Date: 10/01/09 TN No: 08-011
Page 15a.2 (iii) Community Support - (adults) (CS) North Carolina is revising the State Plan to facilitate phase out of the Community Support - Adults service, which will end effective July 1, 2010. Beginning
1/23/2014 TOPICS PHARMACOLOGY: UPDATES AND REVIEW. Elizabeth Reeve MD HealthPartners Medical Group Gillette Children s Specialty Heath Care
PHARMACOLOGY: UPDATES AND REVIEW Elizabeth Reeve MD HealthPartners Medical Group Gillette Children s Specialty Heath Care TOPICS General pharmacology concepts when prescribing for children and adults When
Clinical Practice Guideline: Depression in Primary Care, Adult 4 Taft Court Rockville, MD 20850 www.mamsi.com
Clinical Practice Guideline: Depression in 4 Taft Court Rockville, MD 20850 www.mamsi.com 40 05 17 035 3/03 Once a primary care patient presents with depressive symptoms, the primary care physician makes
Brochure More information from http://www.researchandmarkets.com/reports/3050457/
Brochure More information from http://www.researchandmarkets.com/reports/3050457/ Global Depression Therapy & Treatment Market - Depression drugs and devices, Anxiety Disorders, SSRIs, Global Industry
Reducing Readmissions: The Role of Long Acting Injectable Psychotropic Medications, Gaining Consumer Acceptance,
Reducing Readmissions: The Role of Long Acting Injectable Psychotropic Medications, Gaining Consumer Acceptance, and Peer Counselors Jorge R. Petit, MD President/Founder Quality Healthcare Solutions December
93.087 ENHANCE THE SAFETY OF CHILDREN AFFECTED BY PARENTAL METHAMPHETAMINE OR OTHER SUBSTANCE ABUSE. U. S. Department of Health and Human Services
APRIL 2012 93.087 ENHANCE THE SAFETY OF CHILDREN AFFECTED BY PARENTAL METHAMPHETAMINE OR OTHER SUBSTANCE ABUSE State Project/Program: ROBESON COUNTY BRIDGES FOR FAMILIES PROGRAM U. S. Department of Health
Outpatient Behavioral Health Services Clinical Coverage Policy No. 8-C Provided by Direct-Enrolled Providers Amended Date: August 1, 2014
Table of Contents 1.0 Description of the Procedure, Product, or Service... 1 1.1 Definitions... 1 1.1.1 Psychological Testing... 1 1.1.2 Psychotherapy for Crisis... 1 2.0 Eligibility Requirements... 2
NORTH CAROLINA TREATMENT OUTCOMES AND PROGRAM PERFORMANCE SYSTEM
NC-TOPPS NORTH CAROLINA TREATMENT OUTCOMES AND PROGRAM PERFORMANCE SYSTEM SFY 2014 2015 IMPLEMENTATION GUIDELINES FOR SUBSTANCE ABUSE & MENTAL HEALTH SERVICES Version 11.0, North Carolina Division of Mental
Algorithm for Initiating Antidepressant Therapy in Depression
Algorithm for Initiating Antidepressant Therapy in Depression Refer for psychotherapy if patient preference or add cognitive behavioural office skills to antidepressant medication Moderate to Severe depression
Medication Management of Depressive Disorders in Children and Adolescents. Satya Tata, M.D. Kansas University Medical Center
Medication Management of Depressive Disorders in Children and Adolescents Satya Tata, M.D. Kansas University Medical Center First Line Medications SSRIs Prozac (Fluoxetine): 5-605 mg Zoloft (Sertraline):
TREATMENT-RESISTANT DEPRESSION AND ANXIETY
University of Washington 2012 TREATMENT-RESISTANT DEPRESSION AND ANXIETY Catherine Howe, MD, PhD University of Washington School of Medicine Definition of treatment resistance Failure to remit after 2
